Rhythm Pharmaceuticals Inc (RYTM) Ownership

37.98 ↓0.13 (-0.35%)
As of April 19, 2024, 3:59pm EST.

Institutional Ownership

Goldman Sachs Group Inc is the biggest individual institutional holder of Rhythm Pharmaceuticals Inc (RYTM), owning a total of 10.1 million shares. Combined, the top 39 institutional holders of RYTM own 123.34% of the company with a total of 72.9 million shares.

In the latest ownership report on December 31st 2023, the top 39 institutional holders increased their combined ownership of RYTM by 6.8 million shares. 9 institutions bought 9,727,206 total additional shares and increased their ownership by an average of 96.45%. However 10 institutions sold 2,890,713 total shares and decreased their ownership by an average of 12.95%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Rhythm Pharmaceuticals increased by a net total of 6,836,493 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Goldman Sachs Group Inc16.989%95.636%10,095,8684,935,3272023-12-31
PRIMECAP Management Company13.551%-2.598%8,052,648-214,7732023-12-31
Baker Bros Advisors LP10.767%-4.536%6,398,365-303,9842023-12-31
BlackRock Inc10.688%2.450%6,351,750151,8682023-12-31
RA Capital Management, LLC8.970%-6.090%5,330,412-345,6552023-12-31
Vanguard Group Inc5.430%7.045%3,226,938212,3702023-12-31
NEA Management Company, LLC4.897%0.000%2,909,95602023-12-31
Federated Hermes Inc3.889%-1.298%2,310,955-30,3802023-12-31
State Street Corporation3.712%-6.756%2,206,018-159,8382023-12-31
Perceptive Advisors LLC3.625%465.639%2,154,1101,773,2822023-12-31
Polar Capital Holdings PLC2.945%-30.000%1,750,000-750,0002023-12-31
COMMODORE CAPITAL LP2.608%-25.301%1,550,000-525,0002023-12-31
Rock Springs Capital Management LP2.563%-4.648%1,522,893-74,2302023-12-31
Pictet Asset Manangement SA1.959%0.000%1,163,9611,163,9612023-12-31
Geode Capital Management, LLC1.883%7.088%1,119,12974,0722023-12-31
Checkpoint Capital LP1.228%0.000%730,000730,0002023-12-31
HHG PLC1.047%-41.647%621,892-443,8532023-12-31
Opaleye Management Inc1.027%-6.585%610,000-43,0002023-12-31
Driehaus Capital Management LLC1.008%118.161%598,905324,3812023-12-31
T. Rowe Price Associates, Inc.0.963%172.066%572,297361,9452023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Goldman Sachs Group Inc16.989%95.636%10,095,8684,935,3272023-12-31
PRIMECAP Management Company13.551%-2.598%8,052,648-214,7732023-12-31
Baker Bros Advisors LP10.767%-4.536%6,398,365-303,9842023-12-31
BlackRock Inc10.688%2.450%6,351,750151,8682023-12-31
RA Capital Management, LLC8.970%-6.090%5,330,412-345,6552023-12-31
Vanguard Group Inc5.430%7.045%3,226,938212,3702023-12-31
NEA Management Company, LLC4.897%0.000%2,909,95602023-12-31
Federated Hermes Inc3.889%-1.298%2,310,955-30,3802023-12-31
State Street Corporation3.712%-6.756%2,206,018-159,8382023-12-31
Perceptive Advisors LLC3.625%465.639%2,154,1101,773,2822023-12-31
Franklin Resources Inc3.158%0.001%1,779,465112022-06-30
Polar Capital Holdings PLC2.945%-30.000%1,750,000-750,0002023-12-31
Alkeon Capital Management, LLC2.919%0.000%1,725,16702023-09-30
COMMODORE CAPITAL LP2.608%-25.301%1,550,000-525,0002023-12-31
Rock Springs Capital Management LP2.563%-4.648%1,522,893-74,2302023-12-31
Pictet Asset Manangement SA1.959%0.000%1,163,9611,163,9612023-12-31
Geode Capital Management, LLC1.883%7.088%1,119,12974,0722023-12-31
VR Adviser, LLC1.834%0.000%1,090,00002023-09-30
Mpm Asset Management, LLC1.614%0.000%909,25802022-06-30
FMR Inc1.461%23.796%868,474166,9402023-09-30
Cormorant Asset Management, LLC1.438%41.667%850,000250,0002023-09-30
BRAIDWELL LP1.427%0.000%843,087843,0872023-06-30
Susquehanna International Group, LLP1.379%13.041%784,55590,5132023-03-31
Great Point Partners LLC1.307%691.438%772,000674,4562023-06-30
Checkpoint Capital LP1.228%0.000%730,000730,0002023-12-31
HHG PLC1.047%-41.647%621,892-443,8532023-12-31
Opaleye Management Inc1.027%-6.585%610,000-43,0002023-12-31
Driehaus Capital Management LLC1.008%118.161%598,905324,3812023-12-31
Orbimed Advisors, LLC0.988%0.000%583,642583,6422023-09-30
T. Rowe Price Associates, Inc.0.963%172.066%572,297361,9452023-12-31
Millennium Management LLC0.961%1,192.980%546,906504,6082023-03-31
Assenagon Asset Management SA0.955%-18.195%543,210-120,8162023-06-30
Jacobs Levy Equity Management, Inc.0.672%0.000%378,714378,7142022-06-30
Citadel Advisors Llc0.642%416.337%365,040294,3422023-03-31
D. E. Shaw & Co LP0.625%94.206%355,530172,4612022-12-31
Samsara BioCapital, LLC0.607%0.000%345,29302023-03-31
Amvescap Plc.0.588%0.000%334,273334,2732022-12-31
Rafferty Asset Management, LLC0.539%16.671%306,01343,7252022-12-31
Citigroup Inc0.483%11,911.800%272,187269,9212022-09-30

Mutual Fund Ownership

PRIMECAP Odyssey Aggressive Growth is the biggest individual fund holder of Rhythm Pharmaceuticals Inc (RYTM), owning a total of 5.2 million shares. Combined, the top 34 mutual fund holders of RYTM own 55.16% of the company with a total of 32.7 million shares.

In the latest ownership report on March 28th 2024, the top 34 fund holders increased their combined ownership of RYTM by 23 thousand shares. 2 funds bought 23,590 total additional shares and increased their ownership by an average of 0.66%. However 1 funds sold 539 total shares and decreased their ownership by an average of 0.12%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Rhythm Pharmaceuticals increased by a net total of 23,051 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF3.066%1.276%1,821,74422,9602024-03-28
iShares Russell 2000 ETF2.199%0.048%1,307,0476302024-03-28
iShares Russell 2000 Growth ETF0.780%-0.116%463,322-5392024-03-28
iShares Biotechnology ETF0.659%0.000%391,64002024-03-28

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
PRIMECAP Odyssey Aggressive Growth8.694%-3.644%5,166,310-195,3702023-12-31
PRIMECAP Odyssey Growth4.250%-0.983%2,525,602-25,0602023-12-31
Vanguard Total Stock Mkt Idx Inv3.196%-0.299%1,899,279-5,6862024-02-29
SPDR® S&P Biotech ETF3.066%1.276%1,821,74422,9602024-03-28
Vanguard Instl Ttl Stck Mkt Idx Tr2.948%1.321%1,741,95422,7172023-03-31
Polar Capital Biotech S Inc2.524%0.000%1,500,00002024-02-29
iShares Russell 2000 ETF2.199%0.048%1,307,0476302024-03-28
Federated Hermes Kaufmann Growth2.061%0.000%1,225,00002023-12-31
Federated Hermes Kaufmann R2.061%0.000%1,225,00002023-12-31
Federated Hermes Kaufmann Small Cap Grow1.769%-3.106%1,051,300-33,7002023-12-31
Federated Hermes Kaufmann Small Cap A1.769%-3.106%1,051,300-33,7002023-12-31
Fidelity® Select Biotechnology1.332%-8.786%786,903-75,8002023-11-30
Vanguard Institutional Extnd Mkt Idx Tr1.246%0.357%740,1932,6342024-02-29
BlackRock Health Sciences Opps Inv A1.162%0.000%690,34702024-02-29
BlackRock Health Sciences Trust II1.205%0.000%683,67502023-02-28
BGF World Healthscience A21.111%0.000%660,36702023-12-31
Vanguard Extended Market Index Investor1.068%-0.014%629,331-882023-08-31
Pictet-Biotech P USD1.051%0.000%624,664624,6642023-12-31
BlackRock Health Sciences Term Trust0.977%0.000%580,57502024-02-29
MEDICAL BioHealth EUR Acc0.920%0.000%542,21902023-06-30
Fidelity Small Cap Index0.875%1.603%520,2498,2062024-01-31
Fidelity Select Biotechnology0.871%-34.248%517,403-269,5002023-12-31
Janus Henderson Global Life Sciences0.846%-0.410%499,999-2,0572023-09-30
Janus Henderson Global Life Sciences D0.846%-0.410%499,999-2,0572023-09-30
Fidelity® Small Cap Index0.840%2.789%496,21313,4652023-10-31
Janus Global Life Science A USD0.840%-11.950%476,793-64,7092022-12-31
iShares Russell 2000 Growth ETF0.780%-0.116%463,322-5392024-03-28
Pictet-Global Megatrend Sel I USD0.728%0.000%432,616432,6162023-12-31
UBS: US Equity Small Cap Growth0.714%-46.701%424,131-371,6332023-12-31
Janus Selection Global Life Science AUSD0.717%-14.471%407,795-68,9982023-03-31
Janus Henderson Glb Life Scn I2 USD0.698%-1.586%396,586-6,3922023-05-31
iShares Biotechnology ETF0.659%0.000%391,64002024-03-28
Vanguard US Opportunities Ins USD Acc0.603%-0.693%358,379-2,5002023-12-31
Biotech Growth Ord0.530%0.000%315,00002023-11-30

Discussions

Please log in or register to share your thoughts.

im_drank4/7/24 05:02pm

$RYTM fuck all u greedy bulls

0 Like Report